Mirum Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Mirum Pharmaceuticals

07/08/2024 22:52

* Mirum Pharmaceuticals Inc  MIRM.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.94.  The mean expectation of ten analysts
for the quarter was for a loss of 47 cents per share. Wall
Street expected results to range from -57 cents to -34 cents per
share.
    * Revenue rose 107.7% to $77.88 million from a year ago;
analysts
expected $75.25 million. 
    * Mirum Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 52 cents​.
    * The company reported a quarterly loss of $24.64 million.
    * Mirum Pharmaceuticals Inc shares had risen by 14.5% this
quarter and gained 32.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Mirum
Pharmaceuticals Inc is $63.00 
This summary was machine generated from LSEG data August 7 at
09:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.47          -0.52          Missed
 Mar. 31 2024      -0.48          -0.54          Missed
 Dec. 31 2023      -0.24          -0.66          Missed
 Sep. 30 2023      -0.63          -0.57          Beat